The extent of ischemia identified on stress cardiac magnetic resonance imaging (CMR) was a strong predictor of the composite ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Patients with abnormal findings had worse outcomes down the road. Still unknown is exactly how to modify that risk.

Researchers develop an AI model that uses ECG data to predict the risk for adverse vascular events in patients with migraine.

HeartFlow recently filed a Form S-1 with the SEC to confirm its intent to complete an initial public offering (IPO) and go ...

Utrecht-based TrianecT, a medtech company specialising in acute stroke diagnostics, has secured €1.35M from XO Ventures and ...

The former Emperor of Japan has been admitted to a hospital in Tokyo to undergo treatment for a heart condition, the Imperial ...

This marks the second FDA-cleared ECG-AI device in Tempus’ cardiovascular product suite, following its previously cleared Tempus ECG-AF solution. The new software analyzes resting, non-ambulatory ...

The global ECG Sensor Patches Market, valued at US$0.95 billion in 2024 stood at US$1.05 billion in 2025 and is projected to advance at a resilient ...

Dr. Gérald Kierzek, emergency physician, reveals the hidden nighttime signs and what they could mean for your health.

MyoBioScan: A non-invasive wearable patch for real-time cardiovascular monitoring, integrating ECG acquisition and sweat-based biomarker analysis.

Tempus AI, Inc. (NASDAQ:TEM) saw its stock rise 3% on Wednesday following the announcement that the company obtained 510(k) ...